[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-334836-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-334836-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","modeling-of-brain-tumors-using-in-vitro-in-vivo-and-microfluidic-models-a-review-of-the-current-developments","Modeling of brain tumors using in vitro, in vivo, and microfluidic models: A review of the current developments","","Brain cancers are among the most complex diseases to treat, largely because therapeutic discovery depends on accurately reproducing the brain’s intricate structure and its surrounding tumor microenvironment. This review evaluates key in vitro, in vivo, and microfluidic brain tumor modeling approaches aimed at capturing these challenges, summarizing how current platforms attempt to improve understanding and therapy development. It also highlights limitations and emerging research directions to support more effective treatments and better patient outcomes.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/modeling-of-brain-tumors-using-in-vitro-in-vivo-and-microfluidic-models-a-review-of-the-current-developments/334836/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/modeling-of-brain-tumors-using-in-vitro-in-vivo-and-microfluidic-models-a-review-of-the-current-developments/334836.png","ImageObject",300,407,{"name":42,"@type":43},"Ivy","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is modeling brain tumors difficult for developing therapies?","Question",{"text":63,"@type":64},"Brain tumors and the surrounding microenvironment are highly complex, and replicating that complexity is challenging. Limited accessibility of affected brain regions and biological resistance also hinder therapeutic progress.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What types of brain tumor models are reviewed?",{"text":68,"@type":64},"The review covers laboratory-based models including in vitro and in vivo approaches, as well as animal-based work and microfluidic platforms designed to address modeling challenges.",{"name":70,"@type":61,"acceptedAnswer":71},"What barriers limit effective systemic chemotherapy for brain tumors?",{"text":72,"@type":64},"The blood-brain barrier restricts access of systemic chemotherapy to affected regions. Tumor-specific developmental, genetic, epigenetic, and microenvironmental traits further contribute to resistance to conventional and novel interventions.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},334836,1791492922,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","Heliyon 10 (2024) e31402  \nContents lists available at ScienceDirect  \nHeliyon  \njournal [homepage:](homepage: www.cell.com/heliyon)[ www.cell.com/heliyon](homepage: www.cell.com/heliyon)  \n| Review article\u003Cbr>Modeling of brain tumors using in vitro, in vivo, and microfluidic models: A review of the current developments\u003Cbr>Richu Raju Ra, Nour M. AlSawaftahb, Ghaleb A. Husseinia, b, c, *\u003Cbr>a Biosciences and Bioengineering PhD Program at the American University of Sharjah, Sharjah, United Arab Emirates b Material Science and Engineering Program at the American University of Sharjah, Sharjah, United Arab Emirates c Department of Chemical and Biological Engineering, American University of Sharjah, Sharjah, United Arab Emirates |  |\n| --- | --- |\n| A R T I C L E I N F O\u003Cbr>Index Terms: Brain cancer\u003Cbr>Tumor microenvironment In vitro\u003Cbr>In vivo\u003Cbr>Microfluidics | A B S T R A C T |\n|  | Brain cancers are some of the most complex diseases to treat, despite the numerous advances science has made in cancer chemotherapy and research. One of the key obstacles to identifying potential cures for this disease is the difficulty in emulating the complexity of the brain and the surrounding microenvironment to understand potential therapeutic approaches. This paper discusses some of the most important in vitro, in vivo, and microfluidic brain tumor models that aim to address these challenges. |\n\n1. Introduction  \nThe field of brain tumor research is currently at a critical juncture, requiring a thorough analysis of the various methodologies used to address this challenging disease. This thorough review aims to carefully assess the effectiveness and limitations of current brain tumor models, which are essential to the development of novel therapies. Integrating prior research findings and empirical data is crucial in advancing brain tumor research, leading to more effective treatment options and improved patient outcomes in the fight against brain tumors. This review explores laboratory-based (in vivo and in vitro), animal-based, and cutting-edge microfluidic platforms. Most of the existing reviews only cover the specific models individually, but we aim to consolidate existing studies and findingson brain tumor modeling and present a comprehensive overview that offers researchers and clinicians a holistic perspective on advanced techniques, significant challenges, and emerging directions in this field.  \nExisting literature showed that in 2019, the number of newly diagnosed brain cancer cases was a staggering figure of 347,922, and 246,253 reported deaths globally [1]. The survival rates for patients diagnosed with brain cancer continue to be disappointingly low, despite notable advancements in treatment modalities. The majority of brain metastases arise from primary neoplasms in the lungs, accounting for approximately 40–50 % of reported cases, followed by breast cancers, which contribute to 15–25 % of instances, and melanomas, which account for 5–20 % of occurrences [2]. Primary brain tumors arise from the neural stem cells (NSCs) or originate from neuronal, astrocytic, and oligodendrocytic lineages. As per the Central Brain Tumor Registry of the United States, Gliomas are the primary brain tumor in the adult population, constituting approximately 30 % of all primary brain and central nervous system (CNS) tumors. High-grade gliomas, exemplified by glioblastomas (GBM) and high-grade astrocytomas (HGA), exhibit a dismal prognosis due to their inherent resistance to conventional radio and chemotherapeutic interventions. In contrast, medulloblastomas (MB) are the prevailing brain cancer type within the pediatric population [3].  \n* Corresponding author. Biosciences and Bioengineering PhD Program at the American University of Sharjah, Sharjah, United Arab Emirates.  \nE-mail addresses: [b00075373@alumni.aus.edu](b00075373@alumni.aus.edu) (R. Raju R), [g00051790@aus.edu](g00051790@aus.edu) (N.M. AlSawaftah), [ghusseini@aus.edu](ghusseini@aus.edu) (G.","cbCaieCxPA7xpyrh","https://ap.wps.com/l/cbCaieCxPA7xpyrh","pdf",2957363,22,"English","# Introduction\n## Brain tumor research context and rationale\n## Epidemiology and key brain cancer types\n## Therapeutic challenges and barriers\n## Biological complexity: developmental, genetic, epigenetic and microenvironmental factors","[{\"question\":\"Why is modeling brain tumors difficult for developing therapies?\",\"answer\":\"Brain tumors and the surrounding microenvironment are highly complex, and replicating that complexity is challenging. Limited accessibility of affected brain regions and biological resistance also hinder therapeutic progress.\"},{\"question\":\"What types of brain tumor models are reviewed?\",\"answer\":\"The review covers laboratory-based models including in vitro and in vivo approaches, as well as animal-based work and microfluidic platforms designed to address modeling challenges.\"},{\"question\":\"What barriers limit effective systemic chemotherapy for brain tumors?\",\"answer\":\"The blood-brain barrier restricts access of systemic chemotherapy to affected regions. Tumor-specific developmental, genetic, epigenetic, and microenvironmental traits further contribute to resistance to conventional and novel interventions.\"}]","Modeling of brain tumors using in vitro, in vivo, and microfluidic models: A review of the current developments | PDF",1790008500,55]